Home Biosciences is Europe’s first venture builder fully dedicated to biotech that partners with academics and scientists to transform innovations into life‑changing therapies. It houses each project in a dedicated subsidiary fully financed by Home Biosciences and run by teams focused on day‑to‑day execution with oversight from the core management team. The company follows an asset‑centric operational model aimed at increasing agility and R&D productivity. Proceeds from the new financing will be used to accelerate development of its pipeline and to strengthen the team. The round will allow Home Biosciences to advance its first venture, One Biosciences, and to build a second venture and a broader pipeline of projects. One Biosciences is focused on generating precision medicines by leveraging single‑cell technologies.

Total raised

$15M

Funding rounds

1

Latest round

Seed

Latest activity

Nov 2021